Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel H Cox

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Channels (Austin, Tex.)|January 8, 2014
Alternative splice isoforms of small conductance calcium-activated SK2 channels differ in molecular interactions and surface levelsElizabeth Storer Scholl, Antonella Pirone, Daniel H Cox, et al.
Circulation|June 19, 2012
Suppression of arterial thrombosis without affecting hemostatic parameters with a cell-penetrating PAR1 pepducinPing Zhang, András Gruber, Shogo Kasuda, et al.
Biophysical Journal|September 25, 2007
Modulation of the conductance-voltage relationship of the BK Ca channel by mutations at the putative flexible interface between two RCK domainsHyun-Ju Kim, Hyun-Ho Lim, Seong-Hwan Rho, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|October 8, 2020
PAR1 (Protease-Activated Receptor 1) Pepducin Therapy Targeting Myocardial Necrosis in Coronary Artery Disease and Acute Coronary Syndrome Patients Undergoing Cardiac Catheterization: A Randomized, Placebo-Controlled, Phase 2 StudyAthan Kuliopulos, Paul A Gurbel, Jeffrey J Rade, et al.
Molecular Metabolism|November 1, 2019
PAR2 controls cholesterol homeostasis and lipid metabolism in nonalcoholic fatty liver diseaseRajashree Rana, Andrew M Shearer, Elizabeth K Fletcher, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Channels (Austin, Tex.)|January 8, 2014
Alternative splice isoforms of small conductance calcium-activated SK2 channels differ in molecular interactions and surface levelsElizabeth Storer Scholl, Antonella Pirone, Daniel H Cox, et al.
Circulation|June 19, 2012
Suppression of arterial thrombosis without affecting hemostatic parameters with a cell-penetrating PAR1 pepducinPing Zhang, András Gruber, Shogo Kasuda, et al.
Biophysical Journal|September 25, 2007
Modulation of the conductance-voltage relationship of the BK Ca channel by mutations at the putative flexible interface between two RCK domainsHyun-Ju Kim, Hyun-Ho Lim, Seong-Hwan Rho, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|October 8, 2020
PAR1 (Protease-Activated Receptor 1) Pepducin Therapy Targeting Myocardial Necrosis in Coronary Artery Disease and Acute Coronary Syndrome Patients Undergoing Cardiac Catheterization: A Randomized, Placebo-Controlled, Phase 2 StudyAthan Kuliopulos, Paul A Gurbel, Jeffrey J Rade, et al.
Molecular Metabolism|November 1, 2019
PAR2 controls cholesterol homeostasis and lipid metabolism in nonalcoholic fatty liver diseaseRajashree Rana, Andrew M Shearer, Elizabeth K Fletcher, et al.
Pageof 2